Sensorion
About:
Sensorion is a France-based biopharmaceutical company developing targeted therapeutic solutions for the treatment of vestibular deficits.
Website: https://www.sensorion.com/
Top Investors: Invus, Sofinnova Partners, Redmile Group, Crede CapitalGroup, Aquilo Capital Management
Description:
Sensorion, a Clapiers, France-based biopharmaceutical company specifically dedicated to the development of innovative and targeted therapeutic solutions to treat vestibular deficits.
Total Funding Amount:
98.3M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Clapiers, Languedoc-Roussillon, France
Founded Date:
2009-01-01
Contact Email:
contact(AT)sensorion-pharma.com
Founders:
Christian Chabbert
Number of Employees:
51-100
Last Funding Date:
2024-02-09
IPO Status:
Public
Industries:
© 2025 bioDAO.ai